Table 2 Patient demographics by clinic group at selected time points in study period
June 2010 | June 2011 | May 2012 | ||||
|---|---|---|---|---|---|---|
Early clinics | Late clinics | Early clinics | Late clinics | Early clinics | Late clinics | |
Indicated for ACE/ARB and statin | ||||||
Patients with DM, no. | 1152 | 879 | 1446 | 1179 | 1599 | 1436 |
% with CVD, age 18–39 years | 0.2 | 0.1 | 0.3 | 0.2 | 0.4 | 0.4 |
% with CVD, age 40–54 years | 7.9 | 4.8 | 6.3 | 5.0 | 6.8 | 4.9 |
% age 55–75 years | 91.9 | 95.1 | 93.4 | 94.8 | 92.9 | 94.7 |
Gender | ||||||
% Female | 61.0 | 61.9 | 60.4 | 58.8 | 58.3 | 58.0 |
Medication | ||||||
% with active prescription for ACE/ARB, statin | 47.9 | 47.1 | 49.9 | 45.4 | 62.3 | 47.0 |
Indicated for statin only | ||||||
Patients with DM, no. | 494 | 424 | 607 | 624 | 761 | 720 |
% without CVD, age 18–39 years, last LDL >=100 | 34.2 | 30.9 | 32.8 | 32.2 | 30.6 | 30.7 |
% without CVD, age 40–54 years, last LDL >=100 | 65.8 | 69.1 | 67.2 | 67.8 | 69.4 | 69.3 |
Gender | ||||||
% Female | 63.4 | 57.3 | 61.8 | 58.3 | 61.4 | 57.9 |
Medication | ||||||
% with active prescription for statin | 55.7 | 52.1 | 51.6 | 47.8 | 63.7 | 51.8 |